These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4119813)

  • 1. Effect of candicidin on the human benign hypertrophied prostate gland.
    Keshin JG
    Int Surg; 1973 Feb; 58(2):116-22. PubMed ID: 4119813
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind trial of the effects of candicidin on patients with benign prostatic hypertrophy.
    Abrams PH
    Br J Urol; 1977 Feb; 49(1):67-71. PubMed ID: 65196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Candicidin treatment of benign hypertrophy of the prostate].
    Jensen SK; Hammen S
    Ugeskr Laeger; 1982 Jan; 144(1):26-7. PubMed ID: 6175063
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
    Caine M; Superstine E
    Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Kuo HC
    Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign enlargement of the prostate.
    Blandy JP
    Nurs Mirror Midwives J; 1976 Aug; 143(9):47-51. PubMed ID: 60753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of benign prostatic hypertrophy].
    Pisani E; Montanari E; Trinchieri A
    J Urol (Paris); 1993; 99(6):288-9. PubMed ID: 7516368
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local microwave hyperthermia and benign prostatic hyperplasia induced bladder outlet obstruction.
    Rigatti P; Guzzoni G; Montorsi F
    Adv Exp Med Biol; 1990; 267():433-7. PubMed ID: 1708192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 14. [First experiences with the steel spiral in lieu of the permanent catheter].
    Reuter HJ; Oettinger M
    Arch Esp Urol; 1986 Sep; 39 Suppl 1():65-8. PubMed ID: 2429624
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 16. Male lower urinary tract symptoms and sildenafil.
    Jackson G
    Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of MR imaging and urodynamic findings in benign prostatic hyperplasia.
    Alam AM; Sugimura K; Okizuka H; Ishida J; Igawa M
    Radiat Med; 2000; 18(2):123-8. PubMed ID: 10888045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
    Zhang P; Wu ZJ; Yang Y; Zhang XD
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.